Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
Revenue PerformanceStrong
Percentile Rank93
3Y CAGR+13.0%
5Y CAGR+15.5%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+13.0%/yr
vs +14.1%/yr prior
5Y CAGR
+15.5%/yr
Consistent
Acceleration
-1.1pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
2.1x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
2025$719.89M-1.7%
2024$731.97M+13.6%
2023$644.39M+29.1%
2022$498.99M+14.0%
2021$437.77M+25.1%
2020$349.85M+8.5%
2019$322.36M+9.4%
2018$294.67M+22.7%
2017$240.18M-5.9%
2016$255.16M-